Concourse Financial Group Securities’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 8492 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 8612 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 8614 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 8625 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 8629 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 8562 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 8354 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 8142 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 7839 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 7851 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 7677 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 7571 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 7432 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 7309 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 7067 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 6809 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 6565 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 6365 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 6155 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 6002 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 5921 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 5836 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 5675 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 5705 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 5605 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 5516 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 5352 |
|